Needham raises Cohu stock price target to $54 on HPC growth

Needham raised its price target on Cohu to $54 from $33 while keeping a Buy rating, and Jefferies also lifted its target to $60 from $55. Cohu beat Q1 2026 revenue at $125.1 million versus $122.07 million expected, though EPS of $0.01 missed the $0.03 forecast; management guided Q2 revenue to $144 million, a 15% sequential increase, and sees calendar 2026 revenue up 20% to 25% driven by HPC demand. The stock has already surged 195% over the past year and trades near its 52-week high of $48.17.

Analysis

COHU’s rerating is really a derivative of the AI test spend cycle, not a simple earnings beat. The important second-order effect is that handler and HBM inspection demand tends to arrive in waves as new xPU/HBM designs move from qualification into volume ramps, which can create a multi-quarter backlog of test cell additions rather than a one-quarter pop. That makes the upside more durable than a normal semiconductor capex recovery, but it also means the stock is now pricing in a fairly clean execution path through the next two reporting cycles.

The competitive read-through is more interesting than the headline target hikes: if Cohu is seeing meaningful HPC mix, then the bottleneck is shifting toward specialized test/inspection throughput, which can pressure customers to multi-source and accelerate incremental capex at adjacent vendors. That should be mildly supportive for the broader semiconductor equipment complex, but the beneficiaries are likely narrower names with exposure to high-complexity compute packaging and test, while generic industrial end markets remain a lagging but helpful kicker rather than the main thesis.

The main risk is valuation compression if the market stops extrapolating CY26-27 growth into a straight-line model. At ~28x forward earnings for a mid-cycle equipment name, the stock is vulnerable to any pause in qualification wins, customer digestion after a strong first-half ordering cycle, or margin slippage if the mix shifts away from the highest-margin systems. Near term, the next catalyst is guidance credibility: another raise would validate the AI demand inflection; any hesitation would likely hit the multiple first and the estimate second.

Contrarianly, consensus may be underestimating how much of the move is already about sentiment, not fundamentals. The stock has likely pulled forward a meaningful portion of the bull case, so the better risk/reward is not chasing spot strength but owning optionality around the next two prints or pairing it against a lower-beta equipment name that lacks AI exposure. If HPC orders are real and recurring, the move can extend; if not, the setup becomes a classic momentum-to-fundamentals handoff failure.

Key Decisions for Investors

• Do not add aggressively at current levels; wait for a 5-10% pullback or the next quarterly print before initiating new longs, because the stock is already discounting a clean CY26 growth ramp and any miss could compress the multiple by 15-20%.
• For event-driven exposure, buy COHU call spreads into the next earnings/guidance update (e.g., 1-2 quarters out) to express upside to a further guide raise while capping downside if HPC orders pause.
• Pair trade: long COHU / short a broader semiconductor equipment name with less AI test leverage over a 1-3 month horizon; the thesis is that AI test mix can outperform generic capex recovery, but keep hedge ratio tight because COHU is now more valuation-sensitive.
• If already long, take partial profits into strength above prior highs and trail the position with a hard stop below the last post-earnings breakout level; the reward remains positive, but the asymmetry has narrowed materially.
• Monitor order commentary from other test/inspection and packaging-adjacent names over the next 4-8 weeks for confirmation; if peers do not corroborate HPC capex strength, reduce exposure quickly because the market will likely de-rate the story first.